21 results on '"Arhin, Francis"'
Search Results
2. Comparative Pharmacodynamics of Single-Dose Oritavancin and Daily High-Dose Daptomycin Regimens against Vancomycin-Resistant Enterococcus faecium Isolates in an In Vitro Pharmacokinetic/Pharmacodynamic Model of Infection
3. Comparative In Vitro Activities of Oritavancin, Dalbavancin, and Vancomycin against Methicillin-Resistant Staphylococcus aureus Isolates in a Nondividing State
4. Results from Oritavancin Resistance Surveillance Programs (2011 to 2014): Clarification for Using Vancomycin as a Surrogate To Infer Oritavancin Susceptibility
5. Use of In Vitro Vancomycin Testing Results To Predict Susceptibility to Oritavancin, a New Long-Acting Lipoglycopeptide
6. Pharmacodynamics of a Simulated Single 1,200-Milligram Dose of Oritavancin in an In Vitro Pharmacokinetic/Pharmacodynamic Model of Methicillin-Resistant Staphylococcus aureus Infection
7. Oritavancin Disrupts Membrane Integrity of Staphylococcus aureus and Vancomycin-Resistant Enterococci To Effect Rapid Bacterial Killing
8. Assessment of Oritavancin Serum Protein Binding across Species
9. Comparative In Vitro Activity Profile of Oritavancin against Recent Gram-Positive Clinical Isolates
10. Impact of Human Serum Albumin on Oritavancin In Vitro Activity against Enterococci
11. Oritavancin Kills Stationary-Phase and Biofilm Staphylococcus aureus Cells In Vitro
12. Assessment by Time-Kill Methodology of the Synergistic Effects of Oritavancin in Combination with Other Antimicrobial Agents against Staphylococcus aureus
13. Effect of Polysorbate 80 on Oritavancin Binding to Plastic Surfaces: Implications for Susceptibility Testing
14. Comparative In VitroActivities of Oritavancin, Dalbavancin, and Vancomycin against Methicillin-Resistant Staphylococcus aureusIsolates in a Nondividing State
15. Use of In VitroVancomycin Testing Results To Predict Susceptibility to Oritavancin, a New Long-Acting Lipoglycopeptide
16. Pharmacodynamics of a Simulated Single 1,200-Milligram Dose of Oritavancin in an In VitroPharmacokinetic/Pharmacodynamic Model of Methicillin-Resistant Staphylococcus aureusInfection
17. Oritavancin Kills Stationary-Phase and Biofilm Staphylococcus aureusCells In Vitro
18. Oritavancin Disrupts Membrane Integrity of Staphylococcus aureusand Vancomycin-Resistant Enterococci To Effect Rapid Bacterial Killing
19. Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faeciumIsolates with or without Reduced Susceptibility to Daptomycin in an In VitroPharmacokinetic/Pharmacodynamic Model
20. Comparative Pharmacodynamics of Single-Dose Oritavancin and Daily High-Dose Daptomycin Regimens against Vancomycin-Resistant Enterococcus faeciumIsolates in an In VitroPharmacokinetic/Pharmacodynamic Model of Infection
21. Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.